RxDoctor Payments Data

Tam Mai, MD

Surgery · Naples, FLNPI 1598922825

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Axogen at 42.0% of the total. 2025 is the largest year on record at $2,695, 9.7 times the $278 reported in 2019.

$5,352in general payments, 2019–2025

Across 47 payments — averaging $113.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$2K
  • Vector Surgical, LLC$882
  • Davol Inc.$656
  • Endomagnetics Ltd$565
  • Myriad Genetic Laboratories, Inc.$168
  • Hologic Sales And Service, LLC$123
  • plus $712 from 16 others

What the payments were for

  • Speaking & faculty fees$60011%
  • Travel & lodging$1,56129%
  • Food & beverage$3,19260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,352 in reported general payments places this provider in the 60th percentile of 1,569 surgery providers in Florida.

See all surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$172,137
Medicare patients
338
Services billed
813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$613
Gabapentin106$522
Ondansetron OdtOndansetron80$387
Doxycycline Hyclate18$204

Paid to pharmacies, not to this prescriber.

Other surgery in Naples

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →